| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7B | $9.1B | $9.6B | $11.2B | $9.2B | $7.1B | $1.8B | $6.6B |
| Cost of Revenue | $9.1B | $8.5B | $9.2B | $10.2B | $8.4B | $1.8B | $6.4B | $6.1B |
| Gross Profit | $0.7B | $0.6B | $0.3B | $1.0B | $0.8B | $0.6B | $0.4B | $0.5B |
| R&D Expense | $0.1B | $0.1B | $0.4B | $0.2B | $0.2B | $0.1B | — | — |
| SG&A Expense | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Operating Income | $0.2B | $0.2B | $-0.1B | $0.7B | $0.5B | $0.1B | $0.1B | $0.2B |
| Net Income | $0.5B | $0.1B | $0.2B | $0.6B | $0.6B | $0.3B | $0.3B | $-0.0B |
| EPS (Basic) | $514.46 | $90.62 | $202.21 | $499.66 | $490.36 | $222.52 | $149.91 | $-14.61 |
| EPS (Diluted) | $514.46 | $90.62 | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $7.7B | $7.6B | $7.9B | $7.5B | $6.4B | $6.3B | $5.3B |
| Current Assets | $3.6B | $3.5B | $3.4B | $4.0B | $4.0B | $3.4B | $3.4B | $3.0B |
| Cash & Equivalents | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B |
| Total Liabilities | $3.0B | $2.9B | $2.9B | $2.9B | — | — | — | — |
| Current Liabilities | $1.5B | $1.4B | $1.3B | $1.5B | $1.6B | $1.1B | $1.2B | $0.8B |
| Stockholders' Equity | $5.2B | $4.7B | $4.6B | $5.0B | $4.4B | $3.8B | $3.5B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.7B | $0.7B | $0.1B | $0.3B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.3B | $-0.4B | $-0.3B | $-0.3B | $-0.3B | $-0.3B |
| Capital Expenditures | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $0.0B | $0.0B | $-0.6B | $-0.1B | $0.2B | $-0.1B | $0.0B | $0.2B |